scispace - formally typeset
Search or ask a question

Answers from top 15 papers

More filters
Papers (15)Insight
Again, lorazepam is clearly superior to placebo in such disorders.
INTERPRETATION Intranasal lorazepam is effective, safe, and provides a less invasive alternative to intramuscular paraldehyde in children with protracted convulsions.
Our results indicate that in patients with persistent asthma suboptimally controlled by triamcinolone therapy alone but whose asthma symptoms improve after addition of salmeterol, a substantial reduction (50%) in triamcinolone dose can occur without a significant loss of asthma control.
Lorazepam alone appears to be ineffective and associated with treatment-limiting adverse effects.
Pharmacokinetically, lorazepam appears to be a useful agent in connection with cardiopulmonary bypass operation.
Lorazepam appeared to be as effective as alprazolam in the acute treatment of panic disorder.
If necessary, patients with aspirin-induced asthma can safely take, even on a long-term basis, salicylamide, dextropropoxyphene, benzydamine, guaiacolic ester of salicylic acid, and chloroquine.
In patients with asthma using inhaled corticosteroids formoterol decreased the risk of asthma-related hospitalizations.
Findings support the value of lorazepam in antiemetic regimens and point to the need for further examination of antiemetic combinations.
Reported drug interactions with lorazepam are rare, but more well controlled pharmacokinetic studies are needed of drug interactions with lorazepam.
Lorazepam (2 mg) was more potent than bromazepam (6 mg) in the doses used in this study. The interaction of metoprolol with bromazepam and lorazepam is unlikely to be of clinical significance.
The results indicate that lorazepam has a significantly superior effect with few side-effects and a large safety margin.
These results demonstrate long-lasting effects of even a single dose of lorazepam.
Overall, this study demonstrated favorable pharmacokinetics of intranasal lorazepam in relation to standard administration methods.
Overall, the rate and extent of lorazepam accumulation during multiple dosage were reasonably well predicted by the single-dose kinetic study.

Related Questions

What conditions need a combination prescription of escitalopram with lorazepam?3 answersEscitalopram in combination with lorazepam is used for the treatment of generalized anxiety disorder (GAD).
Can escitalopram be taken with lorazepam?5 answersEscitalopram can be taken with lorazepam, but caution should be exercised due to potential interactions. Escitalopram is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of mood and anxiety disorders. It is considered to have fewer adverse effects and a lower propensity for drug interactions. However, there have been reports of escitalopram inducing mania, especially when given with alprazolam, which is known to boost the efficacy of SSRIs. Therefore, it is important to monitor patients closely when combining escitalopram with lorazepam, as lorazepam is a benzodiazepine used for the treatment of anxiety disorders. The combination may increase the risk of adverse effects or exacerbate symptoms. It is recommended to consult with a healthcare professional before taking these medications together.
How to decrease side effects of lorazepam?5 answersTo decrease the side effects of lorazepam, several strategies can be employed. One approach is to carefully monitor the dosage administered to patients. Studies have shown that lower doses of lorazepam can still be effective in inducing and maintaining sleep, while reducing the occurrence of side effects such as memory impairment and confusion ^[Scharf and Jacoby, 1982] ^[Kales et al., 1979]. Another strategy is to gradually taper off the medication instead of abruptly stopping its use. This can help minimize the occurrence of rebound insomnia and anxiety that may arise after lorazepam withdrawal ^[Scharf and Jacoby, 1982] ^[Kales et al., 1979]. Additionally, combining lorazepam with patient counseling has been found to improve psychological distress and overall quality of life, suggesting that a holistic approach to treatment may help mitigate side effects ^[James et al., 2019]. Overall, careful dosage management, gradual withdrawal, and a comprehensive treatment approach can contribute to reducing the side effects associated with lorazepam use.
Can I take Allegra D if I have asthma?2 answers
Can you take a decongestant with asthma?6 answers
What allergy medicine is safe for asthma?5 answers

See what other people are reading

What are the most effective methods for assessing learning outcomes in various educational settings?
5 answers
The most effective methods for assessing learning outcomes in various educational settings involve utilizing randomized control trials (RCTs) as the 'gold standard' for evaluating educational interventions. Additionally, the assessment process can benefit from a unified assessment process and an online management system that streamlines the assessment process and provides valuable infographics and reports for effective oversight. It is crucial to consider different approaches to measurement, emphasizing generic or disciplinary skills, self-assessment versus objective test-based measures, and discussing the contribution from the education program or institution (value-added). Furthermore, employing a methodological framework that evaluates each learning outcome individually and ranks students based on their overall performance can enhance the assessment process in contexts where final assessments are represented by single quantitative grades.
Can personal lubricant formulations be used as a preventive measure against HIV transmission during sexual intercourse?
4 answers
Personal lubricant formulations have shown potential as preventive measures against HIV transmission during sexual intercourse. Studies have explored the use of lubricants containing anti-viral agents like carrageenan and Dapivirine to reduce the propagation of HIV. Vaginal formulations, including gels, rings, and films, have been developed to release drugs like Dapivirine, Tenofovir, and Maraviroc upon contact with the vaginal medium, aiming to protect women from HIV infection. Innovative delivery devices, such as nonwoven vaginal devices, have been designed to improve gel retention and reduce leakage, showing promising acceptability and performance for vaginal drug delivery. These advancements highlight the potential of lubricant-based formulations in providing protection against HIV transmission, emphasizing the importance of further research and development in this field.
What does an app cost?
4 answers
The cost of apps can vary significantly based on different factors. On average, the cost of an app is around $1.47. However, when considering the development of software projects, the average cost can range from $434,000 for small companies to $2,322,000 for large companies. In the healthcare sector, app-based treatments have shown cost-effectiveness in various conditions. For instance, app-based treatment for female urinary incontinence was found to be cost-effective compared to care-as-usual in Dutch primary care, with lower costs and small mean differences in effects. Similarly, an app designed for treating stress urinary incontinence was deemed a cost-effective first-line treatment, with potential for increasing access to care at a sustainable cost for patients. Therefore, the cost of apps can vary depending on the purpose and context of their development and utilization.
How does rezafungin compare to other antifungal drugs in terms of efficacy and safety?
10 answers
Rezafungin, a novel echinocandin, has been compared to other antifungal drugs, particularly caspofungin, in terms of efficacy and safety across various studies. In the Phase 3 ReSTORE trial, rezafungin demonstrated noninferiority to caspofungin in treating candidemia and invasive candidiasis, with similar efficacy outcomes in immunocompromised patients and across different renal function categories. This is further supported by a patient-level meta-analysis from the STRIVE and ReSTORE trials, which showed comparable 30-day all-cause mortality rates and mycological response between rezafungin and caspofungin, alongside a similar safety profile. Rezafungin's once-weekly dosing regimen is a significant advantage over daily dosing required by other echinocandins, potentially improving patient compliance without compromising safety or efficacy. Its pharmacokinetic profile, characterized by a long half-life, allows for this less frequent dosing while maintaining effectiveness. In terms of safety, rezafungin has shown a low potential for drug-drug interactions, a common limitation among antifungal agents. This attribute enhances its suitability for patients undergoing complex treatment regimens, as demonstrated in studies assessing interactions with common medications. Adverse events associated with rezafungin were generally mild and comparable to those observed with caspofungin. Rezafungin's in vitro activity against a wide range of fungal pathogens, including multidrug-resistant strains, is comparable to or exceeds that of other echinocandins and antifungals, suggesting a broad utility in treating invasive fungal infections. Its efficacy against Candida spp., including fluconazole-resistant strains, and Aspergillus spp., positions rezafungin as a potent option in the antifungal treatment landscape. Overall, rezafungin compares favorably to other antifungal drugs, offering a combination of effective antifungal activity, safety, and a more convenient dosing schedule that could benefit a wide range of patients.
What are some alternative treatments for early onset dementia?
5 answers
Alternative treatments for early-onset dementia include non-pharmacological interventions such as cognitive training, sensory stimulation, behavioral therapy, and animal-assisted therapy. Additionally, cannabinoids like CBD from Cannabis sativa have shown potential in managing behavioral symptoms and neurobiological changes in individuals with early-stage dementia. However, it is crucial to note that no definitive treatment has been found for frontotemporal disorders, but cannabinoid products may help manage treatment-resistant behavioral variants of Frontotemporal dementia. Implementing relationship-centered care approaches, early diagnosis, meaningful activities, and tailored community services can also significantly benefit individuals with early-onset dementia and their caregivers, promoting an enriched and supportive care environment with zero tolerance for marginalization.
Is there strong evidence for APOS therapy in the treatment of osteoarthritis of the knee?
5 answers
There is no strong evidence supporting the use of APOS therapy in the treatment of knee osteoarthritis. Studies have primarily focused on comparing high-dose versus low-dose exercise therapy, injectable ortho-biological treatments like platelet-rich plasma (PRP) and mesenchymal cells, and other biologic therapies. Research indicates that high-dose exercise therapy did not show significant benefits over low-dose therapy, except for slight improvements in knee function during sports and recreation, as well as quality of life. Injectable ortho-biological treatments, including PRP and mesenchymal cells, have shown varying results with no uniform beneficial effects demonstrated. The lack of consistent conclusions on the efficacy of biologic therapies due to product standardization issues and the need for further randomized controlled trials highlight the current uncertainty surrounding APOS therapy for knee osteoarthritis.
How effective is rezafungin in treating fungal infections compared to other antifungal medications?
9 answers
Rezafungin, a next-generation echinocandin, has demonstrated promising efficacy in treating fungal infections, particularly candidemia and invasive candidiasis, compared to other antifungal medications. Its once-weekly dosing regimen, due to a long half-life of around 133 hours, offers a significant advantage in terms of patient compliance and administration convenience. In clinical trials, rezafungin showed non-inferiority to caspofungin, a well-established echinocandin, in terms of 30-day all-cause mortality (ACM) and global response at Day 14, with comparable safety profiles. This was further supported by patient-level meta-analyses from the STRIVE and ReSTORE trials, which also highlighted rezafungin's efficacy with similar 30-day ACM rates and safety to caspofungin. Rezafungin's in vitro activity against a wide range of fungal pathogens, including Candida spp., Aspergillus spp., and Pneumocystis spp., has been extensively documented. It has shown potent activity against Candida spp., including multidrug-resistant strains like Candida auris, and Aspergillus spp., with a broad spectrum of activity that is comparable or superior to other echinocandins like caspofungin, micafungin, and anidulafungin. Moreover, rezafungin has demonstrated a low potential for drug-drug interactions, which is a significant advantage over other antifungal agents that often have severe drug-drug interactions limiting their use. Clinical outcomes in patients with renal impairment also indicate that rezafungin's efficacy is comparable across different levels of renal function, offering a therapeutic option for a broader patient population. Additionally, rezafungin has been effective in treating fungal infections in immunocompromised patients, a group that typically presents a challenge in antifungal therapy. In summary, rezafungin has shown to be an effective antifungal agent with a favorable safety profile, comparable efficacy to other echinocandins, and advantages in dosing frequency and drug-drug interaction potential, making it a valuable addition to the antifungal therapeutic arsenal.
Can cognitive exercises be used as an alternative to traditional physical activity for weight loss?
5 answers
Cognitive exercises can complement traditional physical activity for weight loss by enhancing self-regulation and self-efficacy, crucial for maintaining health behaviors. Studies suggest that cognitive training can improve weight maintenance by strengthening executive functions like inhibition and working memory, leading to better adherence to dietary and physical activity recommendations. Additionally, cognitive interventions tailored for excess weight individuals have shown promise in reducing BMI and improving cognitive measures, eating behaviors, and physical exercise habits. Integrating cognitive training with physical exercise, as seen in programs combining aerobic, coordination, and cognitive training, can lead to enhanced physical and cognitive performance, potentially offering a comprehensive approach to weight loss. Therefore, incorporating cognitive exercises alongside traditional physical activity may offer a holistic strategy for weight management.
What are the specific studies that have investigated the effectiveness of psilocybin therapy in treating anxiety symptoms?
5 answers
Studies investigating the effectiveness of psilocybin therapy in treating anxiety symptoms include a systematic review that highlighted significant reductions in anxiety symptoms post-psilocybin administration, along with improvements in overall well-being and life satisfaction. Additionally, a study conducted at Johns Hopkins Bayview Medical Center demonstrated successful treatment of severe anxiety with a single oral dose of psilocybin, particularly in patients facing cancer-related distress. Furthermore, a pilot study focusing on US Military Veterans with severe PTSD is set to examine the safety and efficacy of psilocybin administration sessions in alleviating anxiety symptoms. These studies collectively showcase the potential of psilocybin therapy in effectively addressing anxiety symptoms in various patient populations.
How do hybrid healthcare models compare to traditional models in terms of cost-effectiveness and efficiency?
5 answers
Hybrid healthcare models, combining face-to-face consultations with telemedicine, have shown promise in various studies. In the context of rheumatoid arthritis patients during the COVID-19 pandemic, a hybrid care modality was found to be non-inferior to traditional in-person consultations in achieving patient-reported outcomes. Additionally, in healthcare education, the development of cost-effective and configurable hybrid simulation platforms has been highlighted as beneficial for educators to simulate different scenarios effectively. These platforms, utilizing standardized patients and wearable/web-based technologies, have demonstrated effectiveness in enhancing student learning outcomes and confidence in handling real-world healthcare scenarios, indicating their potential for improving cost-effectiveness and efficiency in healthcare training and education.
What is the impact of boiling ginger on secondary metabolites like gingerol and shogaol?
5 answers
Boiling ginger has a significant impact on secondary metabolites like gingerol and shogaol. The process of boiling ginger rhizomes alters the composition of these active compounds due to the influence of temperature. Studies have shown that the thermal processing of ginger can lead to changes in the content and transformation of compounds, affecting the overall composition of the plant matrix. Additionally, the metabolism of ginger compounds like gingerols and shogaols in humans has been studied, revealing that these components undergo ketone reduction and cysteine conjugation pathways, producing various metabolites with potential health benefits. Therefore, boiling ginger can impact the levels and types of secondary metabolites present, potentially influencing the therapeutic properties of the plant.